LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Suanfarma
03 1TAPI Technology & API Services
04 1AASraw Biochemical Technology Co., Ltd
05 1Alcami
06 1Apotex Pharmachem
07 1Aspen Biopharma Labs
08 1Asymchem Laboratories
09 1Chongqing Huapont Pharmaceutical
10 1Cipla
11 1DEAFARMA
12 1Emcure Pharmaceuticals
13 2Fareva
14 1Formosa Laboratories
15 1Fresenius Kabi AB Brunna
16 1Fresenius Kabi Oncology Limited
17 1Guangzhou Tosun Pharmaceutical
18 1Hetero Drugs
19 1Ind Swift Laboratories Limited
20 1Jiwan Pharmaceutical Technology Co., Ltd
21 1Mac-Chem Products (India) Pvt.Ltd
22 1Nanjing Bold Chemical
23 1Natco Pharma
24 1Nishchem International Pvt. Ltd
25 1SGMR Pharmaceuticals
26 1SYNTHON Chemicals GmbH & Co. KG
27 1Sakar Healthcare
28 2ScinoPharm Taiwan, Ltd
29 2Shilpa Medicare
30 1Shouyuan Chemical
31 1Sichuan Xieli Pharmaceutical
32 1Stason Pharmaceuticals, Inc.
33 1Sun Pharmaceutical Industries Limited
34 1Synthimed Labs
35 1Synthon Pharmaceuticals
36 1Tai Heng Industry Co., Ltd
37 1Teva Pharmaceutical Industries
38 1Unipex
39 1Yangtze River Pharmaceutical Group
40 1Zhejiang Hisun Pharmaceutical
41 1Zydus Lifesciences
01 1Canada
02 11China
03 1France
04 1Germany
05 16India
06 2Israel
07 1Italy
08 2Luxembourg
09 1Netherlands
10 1Spain
11 1Sweden
12 3Taiwan
13 3U.S.A
01 13Active
02 9Inactive
03 22Blank
01 1Expired
02 10Valid
03 33Blank
01 1222MF10240
02 1223MF10014
03 1223MF10081
04 1223MF10107
05 1227MF10034
06 1228MF10140
07 38Blank
01 1WC-0003
02 1WC-0014
03 1WC-0041
04 1WC-0115
05 1WC-0138
06 1WC-0147
07 1WC-0159
08 1WC-0275
09 36Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19034
Submission : 2005-12-16
Status : Active
Type : II
Certificate Number : R1-CEP 2014-099 - Rev 01
Issue Date : 2021-12-20
Type : Chemical
Substance Number : 2406
Status : Valid
Available Reg Filing : ASMF, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-25
Pay. Date : 2012-11-15
DMF Number : 25897
Submission : 2012-03-31
Status : Active
Type : II
NDC Package Code : 58623-0041
Start Marketing Date : 2019-09-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-04-21
Pay. Date : 2015-08-10
DMF Number : 20338
Submission : 2007-03-09
Status : Active
Type : II
Certificate Number : CEP 2024-160 - Rev 00
Issue Date : 2024-08-30
Type : Chemical
Substance Number : 2406
Status : Valid
Registration Number : 222MF10240
Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY
Initial Date of Registration : 2010-10-13
Latest Date of Registration : --
NDC Package Code : 46014-1009
Start Marketing Date : 2015-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2022-10-21
Registration Number : 20221021-209-J-1387
Manufacturer Name : Excella GmbH & Co. KG
Manufacturer Address : Nurnberger Strasse 12, 90537 Feucht, Germany
Available Reg Filing : CN |
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-05-11
Pay. Date : 2018-04-03
DMF Number : 21901
Submission : 2008-09-27
Status : Active
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm :
NDC Package Code : 62756-428
Start Marketing Date : 2023-02-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19496
Submission : 2006-04-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19025
Submission : 2005-12-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19211
Submission : 2006-02-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26202
Submission : 2012-07-05
Status : Inactive
Type : II
Certificate Number : CEP 2017-114 - Rev 01
Issue Date : 2024-07-03
Type : Chemical
Substance Number : 2406
Status : Valid
NDC Package Code : 61200-104
Start Marketing Date : 2015-05-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
We have 41 companies offering anastrazole
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?